.@GradSchoolSinai: By the Numbers ✨Fully integrated w/ @IcahnMountSinai ✨#11 in @NIH funding: $495.1 M ✨Embedded in @MountSinaiNYC, one of the largest academic medical systems in NY metropolitan area 👉Here's a recap of who we are & how we excel: https://t.co/Oke3NntUOg

Mount Sinai researchers have received a $25 million, five-year NIH grant to study Alzheimer’s disease risk among Chinese Americans—one of the fastest-growing yet most underrepresented populations in dementia research. Led by Drs. Clara Li, Jessica Spat-Lemus, Ankit Parekh, and

Adults with genetic conditions often spend years searching for answers. At Mount Sinai’s Adult Genetics Program, our team helps connect those answers — bringing clarity, coordinated care, and hope. 🎥 Meet our team: https://t.co/HbG69W2W0o #MedicalGenetics #GeneticCounseling

Mount Sinai researchers mapped one of the most detailed protein networks of the brain to date — revealing how cell communication falters in #Alzheimers and spotlighting AHNAK as a key player. https://t.co/X81ZgtU2tx #AlzheimersDisease #AlzheimersResearch

We’re honored to join the @BDSRA community as a Batten Disease Clinical Center of Excellence Affiliate, dedicated to supporting patients and families living with Batten disease. #RareDisease #BattenDisease

Congrats to Dr. Kuan-lin Huang & collaborator @wzehrakorkusuz named Phase 1 winners of the NIH/NEI S-Index Challenge! Their project proposes a new way to measure impact — crediting scientists for data that are high-quality, rapidly shared & reused to drive discovery. #openscience

Rare disease community members are invited to join us with @RareDiseases and NORD Centers of Excellence for a special day of connection, fun, and education at the Bronx Zoo! Saturday, October 4, 10am-1pm, Register Today! https://t.co/2bYwgOIEcl #RareDiseases #RareDiseaseCommunity

AI + routine labs help clarify genetic risk. @SinaiGenetics modeled 1,600 variants across 10 diseases using 1M+ health records, moving past binary labels. https://t.co/7acY5aujr8 #precisionmedicine #genetics #AIinHealthcare #AIinMedicine @IainSForrest @DoGenetics

Our new positioning paper is out! Collaborated with Dr. Amy Justice from @Yale and investigators from the #VA and #DOE to showcase how this partnership is driving innovation in #precisionhealth https://t.co/ax37znZilr @IcahnMountSinai @SinaiGenetics @AIHealthMtSinai @SinaiImmunol

NEW STUDY by @g_e_hoffman @panos_roussos, et al. @Icahnmountsinai presents transcriptional analysis of primary microglia from 189 human postmortem brains. These data further our understanding of key role #Microglia have in AD biology. OUT NOW @NatureNeuro https://t.co/UzqwxsUEzx

New @SinaiGenetics study shows Viagra & Cialis may help treat #MitochondrialDisease. Tadalafil improved cell function & symptoms in patients, offering a potential personalized therapy using already-approved drugs https://t.co/wjT0DjUuhq #DrugRepurposing #Genetics #RareDisease

A comprehensive phenotypic & genotypic review of GMPPA‑CDG, analyzing 26 cases. Key insights: novel genotype‑phenotype correlations, expanded clinical spectrum. Findings pave way for improved diagnostic precision & therapeutic strategies: https://t.co/ASiRtWupTv #CDG #RareDisease

“AI is not a luxury or a side pursuit in genomic medicine — it’s a necessity.” Inga Peter of @SinaiGenetics on how AI is helping unlock the full potential of #genomics to advance precision medicine: https://t.co/RvMsYPVCA3 @modrnhealthcr #AIinHealthcare #precisionmedicine

A newborn w/a rare liver disorder just became the first patient to receive a personalized #CRISPR-based #geneediting treatment. "We are at day one of the future of how we are going to treat different diseases," said Brian Brown of @IcahnInstitute

One patient. Two rare diseases: This case of combined PGM1-CDG & Leigh syndrome reveals the devastating metabolic effects when energy production & glycosylation pathways both fail. A poignant reminder of the complexity behind rare disease. https://t.co/2ACSYV44wg #rarediseases

🧠🍺 Pint of Science is coming to NYC May 19–21! Don’t miss Dr. Eva Morava of @SinaiGenetics on May 19 as she explores how sugar antennas shape our health. Three nights of science, stories, and pints at Slattery’s Midtown Pub. 🍻 https://t.co/t1PXNHZDIH #Pint25 #nycevents

Coming Q4 2025 to the Target ALS Data Engine: the largest single-cell RNA-seq dataset for #ALS, funded by Target ALS and generated by Dr. @panos_roussos lab at @IcahnMountSinai: https://t.co/6Auz2zoyP1 @SinaiBrain @MountSinaiPsych @SinaiGenetics

Interested in #LongReadSequencing? We are delighted that @GangFang_1 (Professor @IcahnMountSinai) is joining us at #FOGBoston, sharing insights on detecting DNA modifications using long read sequencing. Register now: https://t.co/a0MzT52RGU

New study finds that germline variants - often overlooked in cancer care - can shape tumor behavior and influence treatment response. A step toward truly personalized #oncology. https://t.co/ZZ0kG4FBGi @ZeynepHG @EsaiMyvizhi #Genomics #Cancer #PrecisionMedicine #Proteogenomics

“This cements the biological significance of a class of small non-coding genes in NDDs,” said first author Daniel Greene. Link to paper: https://t.co/ecJiNAHg2W #Neurogenetics #noncodingRNA #epilepsy #precisionmedicine